Tumour heterogeneity and the evolution of polyclonal drug resistance
Rebecca A. Burrell(Cancer Research UK Cambridge Center), Charles Swanton(Cancer Research UK)
Cited by 419
Related Papers
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
|Genome biology|2016|1.3k
Intratumor Heterogeneity: Evolution through Space and Time
|Cancer Research|2012|926
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
|Cell|2021|875
Resolving genetic heterogeneity in cancer
|Nature Reviews Genetics|2019|689